These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36343848)

  • 1. Emerging roles of PHLPP phosphatases in the nervous system.
    Mallick A; Sharma M; Dey CS
    Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
    Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
    Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble.
    Sharma M; Dey CS
    Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPP1 splice variants differentially regulate AKT and PKCα signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus.
    Jackson TC; Verrier JD; Semple-Rowland S; Kumar A; Foster TC
    J Neurochem; 2010 Nov; 115(4):941-55. PubMed ID: 20819118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
    Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
    J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
    Rajala RV; Kanan Y; Anderson RE
    Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
    Xiong X; Li X; Wen YA; Gao T
    J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
    Brognard J; Sierecki E; Gao T; Newton AC
    Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling.
    Baffi TR; Cohen-Katsenelson K; Newton AC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHLPP Signaling in Immune Cells.
    Lordén G; Lam AJ; Levings MK; Newton AC
    Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHLiPPing the switch on Akt and protein kinase C signaling.
    Brognard J; Newton AC
    Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of survival signalling pathways by the phosphatase PHLPP.
    O'Neill AK; Niederst MJ; Newton AC
    FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatase PHLPP controls the cellular levels of protein kinase C.
    Gao T; Brognard J; Newton AC
    J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHLPP Inhibitor NSC74429 Is Neuroprotective in Rodent Models of Cardiac Arrest and Traumatic Brain Injury.
    Jackson TC; Dezfulian C; Vagni VA; Stezoski J; Janesko-Feldman K; Kochanek PM
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
    Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
    PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.